Astrana Well being, Inc. (NASDAQ:ASTH) is one in every of the perfect small cap shares to purchase for 10x potential. On Could 8, Baird lifted the value goal on Astrana Well being, Inc. (NASDAQ:ASTH) to $45 from $40, sustaining an Outperform score on the shares. The agency up to date its mannequin on the inventory after it launched its fiscal Q1 2026 monetary outcomes, stating that the story is strengthening and the MA margin upside is taking form. The corporate additionally obtained a score replace from Needham the identical day, with the agency lifting the value goal on Astrana Well being, Inc. (NASDAQ:ASTH) to $41 from $30 and reaffirming a Purchase score on the shares.
In its monetary outcomes for fiscal Q1 2026 launched on Could 7, Astrana Well being, Inc. (NASDAQ:ASTH) reported complete income of $965.1 million, reflecting a 56% yr over yr development. It additionally reported adjusted EBITDA of $66.3 million, up 82% yr over yr, and free money circulation of $64.1 million, up 372% yr over yr.
Astrana Well being, Inc. (NASDAQ:ASTH) is a physician-centric, technology-powered, risk-bearing healthcare administration firm that operates as an built-in healthcare supply platform. It supplies companies together with Multi-Specialty Care, Main Care, Radiology, Quick Care, and Laboratory.
Whereas we acknowledge the potential of ASTH as an funding, we imagine sure AI shares supply better upside potential and carry much less draw back threat. If you happen to’re searching for a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
READ NEXT: 15 Shares That Will Make You Wealthy in 10 Years AND 12 Finest Shares That Will All the time Develop.
Disclosure: None. Observe Insider Monkey on Google Information.